Analytical performance of specific-protein assays on the Abbott Aeroset system.

Inuit. Lancet 1997;349:1221–2. 3. Hegele RA, Young TK, Connelly PW. Are Canadian Inuit at increased risk for coronary heart disease? J Mol Med 1997;74:364–70. 4. Hegele RA. The genetic basis of atherosclerosis. Int J Clin Lab Res 1997;27:2–13. 5. Tillett WS, Francis T Jr. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 1930;52:561–85. 6. Rifai N, Ridker PM. High-sensitivity C-reactive protein. a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403–11. 7. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999;19:1986–91. 8. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000;343: 1179–82. 9. Cao H, Hegele RA. Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000;45:100–1. 10. Cao H, Hegele RA. Human cathepsin S gene (CTSS) promoter 225G/A polymorphism. J Hum Genet 2000;45:94–5. 11. Young TK, Nikitin YP, Shubnikov EV, Astakhova TI, Moffatt MEK, O’Neil JD. Plasma lipids in two indigenous arctic populations with low risk for cardiovascular disease. Am J Hum Biol 1995;7:223–36.